Back to All Events

[Virtual] ACCJ Outstanding Achievement Award – Dr. Tatsuya Kondo

Speaker: Dr. Tatsuya Kondo, Chief Executive Officer at Medical Excellence JAPAN

Hosting Committees: Healthcare, Digital Health, Medical Devices and Diagnostics, Pharmaceuticals, Regenerative Medicine and Bioscience, Dietary Supplements

Member Fee: ¥600

Guest Fee: ¥1,200

Registration/Cancellation Deadline:

Thursday, October 8, (9:00am)

This event will be hosted as a webinar. Instructions for joining the virtual meeting will be sent to registered attendees after the above stated deadline.

Dr. Kondo.jpg

Event Overview:

Dr. Tatsuya Kondo, Chief Executive Officer of Medical Excellence JAPAN, Chief Executive Emeritus of PMDA, has been selected to receive the American Chamber of Commerce in Japan (ACCJ) Outstanding Achievement Award for his significant contributions to improving the Japanese healthcare system, helping to harmonize the country’s regulatory system, and contributing to the US–Japan partnership.

Under Dr. Kondo’s leadership, Japan’s Pharmaceutical and Medical Devices Agency (PMDA) evolved into a world-class regulatory body. The PMDA was then able to reverse the drug and device lag that had, for many years, delayed Japanese patients’ access to some of the world’s most innovative medicines and care. His efforts were pivotal in bringing together the business community with government stakeholders to streamline processes and implement much needed reforms. Through skillful application of regulatory science and a keen understanding of the levers of innovation, he contributed greatly to ensuring that patients in Japan have access to innovations that not only save lives but improve quality of life.

The ACCJ membership, Board of Governors, and the Healthcare Committee will present this award to Dr. Kondo at a special event at which he will reflect on his career achievements and share his thoughts on the future of healthcare in Japan.

John W. Carlson III, Chair
William Bishop, Yuko Kidoguchi, Takeo Morooka, Toshio Nagase, and Mika Shirai, Vice-Chairs
ACCJ Healthcare Committee

NOTE 1: This event is ON THE RECORD.

NOTE 2: Please note that, as with all guest presentations, the content and comments of the speakers reflect their own opinions and do not necessarily represent the opinions or policies of the ACCJ.

NOTE 3: If you cancel after the stated deadline, the full meeting fee will be charged to your account.

Previous
Previous
October 5

[Virtual] Post-Covid: How Will Public Affairs and Stakeholder Engagement Change in the New Environment?

Next
Next
October 15

The Changing Landscape of Merger Control in Japan - What you need to know to get the deal through